Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

By Giuseppe Curigliano, D. Cardinale, S. Dent, C. Criscitiello, O. Aseyev, D. Lenihan, C. Cipolla. Ca, 2016

705 citations recorded by the source corpus.

Answer questions and earn CME/CNE

Subfields: Cardiology and Cardiovascular Medicine, Oncology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/3be5fa856d6c80b9bd17439a1cc5c42ba6f15d7e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Kathryn H. Schmitz
2. Alpa V. Patel
3. Kristin L Campbell
4. Kerri M. Winters-Stone
5. J. Wiskemann
6. A. May
7. Trisha Hue
8. Lynn H. Gerber

Citations in the corpus

• Exercise Guidelines for Cancer Survivors: Consensus statement from International Multidisciplinary Roundtable (2019, background): “Furthermore, risk of developing heart disease may be elevated by some cancer treatments, and cardiovascular mortality is emerging as a major competing cause of death in cancer survivors along with cancer recurrence (3,4).”